Article 14(1)(a) health claim referring to a reduction of a disease risk,ProteQuine®,ProteQuine® elevates/maintains the level of ScIgA on mucous membranes. Decreased or insufficient level of ScIgA is a risk factor in the development of common cold or influenza,Q-2008-397,
Article 14(1)(a) health claim referring to a reduction of a disease risk,ProteQuine® in combination with bovine lactoferrin,ProteQuine® in combination with bovine lactoferrin elevates/maintains the level of ScIgA on mucous membranes. Decreased or insufficient level of ScIgA is a risk factor in the development of common cold with sore throat and combination of ProteQuine® with bovine lactoferrin reduces the risk of the development of sore throat,Q-2008-398,
Article 14(1)(b) health claim referring to children's development and health, Lactobacillus delbrueckii subsp. bulgaricus strain AY/CSL (LMG P-17224) and Streptococcus thermophilus strain 9Y/CSL (LMG P-17225),Maintaining the gut health by normalizing the intestinal flora,Q-2008-273,
Article 14(1)(b) health claim referring to children's development and health,Beta palmitate,Beta palmitate enrichment contributes to increase calcium absorption,Q-2008-172,